Search

Join Colin & Linda McArthur for their annual Isle of Wight walk in support of Retina UK. Last year's event raised a record-breaking £6,000+!

• Walks & Treks
• Isle of Wight

We employ a number of full and part-time staff. Our office is in Buckingham.

Our vision is a world where everyone with inherited sight loss is able to live a fulfilling life.

Biotechnology company MeiraGTx has announced encouraging news from its phase 1/2 clinical trial of botaretigene sparoparvovec (previously known as AAV-RPGR), a gene therapy aimed at X-linked retinitis pigmentosa caused by faults in the RPGR gene.

• News
• Retinitis pigmentosa

This page explains the different types of genetic tests: diagnostic testing, predictive testing, carrier testing and research testing

Prof Mariya Moosajee at Moorfields Eye Hospital has asked us to share the message below about the clinical trial she is running. This trial is for a treatment that targets a particular section of the USH2A gene.

• News
• Usher syndrome

Do you know your facts from your fiction? Host a quiz for Retina UK and raise vital funds for our ground-breaking work.

• Live Streaming
• United Kingdom

Join Lauren as she chats with Paula McGrath, Deputy CEO of Retina UK, about the 2025 Sight Loss Survey

• Podcast
• Audio

Stem cells are a special type of cell, which under the right conditions can be encouraged to grow into any other type of cell in the body, including retinal cells (rods, cones and retinal pigment epithelial cells).

Growth factors are substances that promote the health and function of cells and tissues in the body.